The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,500.00
Bid: 4,460.00
Ask: 4,500.00
Change: 0.00 (0.00%)
Spread: 40.00 (0.897%)
Open: 4,500.00
High: 4,500.00
Low: 4,500.00
Prev. Close: 4,480.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of holding in BF&M Limited

6 Jun 2023 12:00

RNS Number : 8288B
Camellia PLC
06 June 2023
 

6 June 2023

Camellia Plc

(the "Company" or "Camellia")

 

Sale of holding in BF&M Limited ("BF&M")

 

 

Camellia is pleased to announce it has entered into an agreement for the sale of its entire holding of 3,394,403 shares (approximately 36.9%) in BF&M, one of its associate companies, to Bermuda Life Insurance Company Limited, a subsidiary of Argus Group Holdings Limited for a cash consideration totalling US$100.0 million (approximately £80.4 million), a premium of 34% to the closing price of a BF&M share on 5 June 2023 and a premium of 31% to the book value of Camellia's holding as at 31 December 2022. Any special dividend declared and paid by BF&M (if any) between the signing of the agreement and completion will be deducted from the cash consideration. This sale represents a further step in Camellia's policy of divesting non-core assets.

 

The disposal is conditional on the satisfaction of certain conditions, including regulatory and tax approvals and notifications in a number of jurisdictions, and the satisfaction of customary conditions precedent. Subject to the satisfaction or waiver of these conditions, completion is expected in Autumn 2023.

 

It is possible that taxes and/or fees may become payable in securing the necessary pre-closing approvals and notifications although such amount cannot be determined until the required applications have been submitted. If Camellia's share of such items exceeds agreed thresholds then the Company has the ability to terminate the contract should it so wish. The purchaser has the same termination right in respect of their share of such costs.

 

Whilst completion of the transaction is not expected until Q4 2023 and therefore the exact use of proceeds may vary depending on circumstances between now and completion, the receipt of the funds realised by this sale, together with funds raised from the disposal of other non-core assets, will enable the Company to accelerate its development programme and continue to diversify its agricultural production by crop and geographic location. The Board considers Camellia's shares to be significantly undervalued and, in the event of any surplus funds arising, will also therefore consider the merit of returning these to shareholders by means of a share buy-back. The Company may, in the meantime, undertake a modest buyback exercise in accordance with the authority given at the Annual General Meeting.

 

BF&M Limited is the holding company of the BF&M group of companies ("BF&M Group") which is a Bermuda listed insurance group operating in Bermuda and the Caribbean. The two largest operating companies within the BF&M Group are BF&M Life Insurance Company Limited, a leading provider of life, health and pensions products, and BF&M General Insurance Company Limited, the leading general insurer providing all forms of property, casualty, motor and marine products.

 

Over recent years BF&M's results have been volatile and in 2022 have been materially adversely impacted by the fluctuations in financial markets and this, together with increased underwriting exposure, has led Camellia to view this investment as beyond its risk appetite.

 

In the year ended 31 December 2022 Camellia's share of the results of BF&M was a loss of £3.7 million (2021: profit of £6.4 million). 

 

Camellia's net assets attributable to the BF&M holding as at 31 December 2022 was £61.5 million and the value of the shares using the closing price for BF&M shares on 5 June 2023 was £59.9 million. The sale is expected to generate a gain on disposal which will be calculated at completion of the transaction.

 

Argus Group Holdings Limited is significant Bermuda listed multi-line insurance and financial services organisation offering a full range of insurance, pensions and investment products internationally. 

 

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

H/Advisers Maitland

PR

William Clutterbuck 07785 292617

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSSLFSMEDSELM
Date   Source Headline
26th Oct 20117:00 amRNSInterim Management Statement
8th Sep 201112:44 pmRNSCompany Secretary Change
5th Sep 201111:15 amRNSHalf Yearly Report
25th Aug 201112:00 pmRNSHalf Yearly Report
10th Jun 20112:00 pmRNSResult of AGM
9th Jun 201112:24 pmRNSAGM Statement
2nd Jun 20114:25 pmRNSAnnual Information Update
11th May 20113:27 pmRNSAnnual Report 2010, notice of meeting, proxy form
5th May 20111:12 pmRNSDisposal
28th Apr 201112:47 pmRNSAnnual Financial Report
30th Mar 201112:06 pmRNSInterim Management Statement
11th Jan 20114:35 pmRNSPrice Monitoring Extension
27th Oct 20103:16 pmRNSInterim Management Statement
7th Oct 201010:40 amRNSDisposal
8th Sep 20101:42 pmRNSDisposal
3rd Sep 20103:57 pmRNSDoc re. Interim Report 2010
26th Aug 20109:58 amRNSHalf Yearly Report
7th Jun 201010:46 amRNSResult of AGM
3rd Jun 201012:33 pmRNSAGM Statement
2nd Jun 201010:22 amRNSAnnual Information Update
6th May 20104:06 pmRNSAnnual Financial Report
29th Apr 20103:04 pmRNSAnnual Financial Report
15th Apr 20102:08 pmRNSDisposal
1st Apr 201011:10 amRNSAppointment of Joint Managing Directors
26th Mar 201010:30 amRNSDirectorate Change
25th Mar 201011:59 amRNSInterim Management Statement
8th Mar 20107:00 amRNSDisposal
5th Mar 20107:00 amRNSStatement Re Siegfried Holding AG
28th Oct 20093:20 pmRNSInterim Management Statement
13th Oct 200910:06 amRNSCircular regarding change of auditor
14th Sep 20094:00 pmRNSDisposal
8th Sep 200910:44 amRNSHalf Yearly Report
27th Aug 200911:00 amRNSHalf Yearly Report
29th Jun 20094:40 pmRNSSecond Price Monitoring Extn
29th Jun 20094:35 pmRNSPrice Monitoring Extension
10th Jun 20094:40 pmRNSSecond Price Monitoring Extn
10th Jun 20094:35 pmRNSPrice Monitoring Extension
4th Jun 20091:40 pmRNSResult of AGM
3rd Jun 20094:40 pmRNSSecond Price Monitoring Extn
3rd Jun 20094:35 pmRNSPrice Monitoring Extension
3rd Jun 200912:12 pmRNSAGM Statement
29th May 20092:55 pmRNSAnnual Information Update
6th May 20092:00 pmRNSAnnual Report and Accounts
28th Apr 20096:26 pmRNSAnnual Financial Report
26th Mar 20092:20 pmRNSInterim Management Statement
2nd Feb 20094:35 pmRNSPrice Monitoring Extension
3rd Dec 20082:23 pmRNSDirector/PDMR Shareholding
24th Nov 20083:37 pmRNSHolding(s) in Company
21st Oct 20084:44 pmRNSSecond Price Monitoring Extn
21st Oct 20084:37 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.